Publication | Closed Access

Efficacy of Vemurafenib Treatment in 43 Metastatic Melanoma Patients with BRAF Mutation. Single-Institute Retrospective Analysis, Early Real-Life Survival Data

OncologyBraf MutationMelanomaPathologyCancer TreatmentMedicineRadiation OncologyMolecular OncologyVemurafenib TreatmentMetastatic Melanoma Patients